Cryptophycin unit B analogues
Drug conjugates using toxic payloads are a promising approach for selectively combating cancer while sparing healthy tissue. The lack of highly cytotoxic and at the same time selective therapeutics against cancer is an ongoing challenge. Cryptophycins are a class of cyclic depsipeptides renowned for...
Saved in:
| Main Authors: | Thomas Schachtsiek, Jona Voss, Maren Hamsen, Beate Neumann, Hans-Georg Stammler, Norbert Sewald |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Beilstein-Institut
2025-03-01
|
| Series: | Beilstein Journal of Organic Chemistry |
| Subjects: | |
| Online Access: | https://doi.org/10.3762/bjoc.21.40 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Towards Aptamer-Targeted Drug Delivery to Brain Tumors: The Synthesis of Ramified Conjugates of an EGFR-Specific Aptamer with MMAE on a Cathepsin B-Cleavable Linker
by: Vladimir A. Brylev, et al.
Published: (2024-11-01) -
Homogeneous antibody-drug conjugates with dual payloads: potential, methods and considerations
by: Miao Wen, et al.
Published: (2025-12-01) -
Understanding the Toxicity Profile of Approved ADCs
by: Pablo Ballestín, et al.
Published: (2025-02-01) -
The Impact of Conjugation Mode and Site on Tubulysin Antibody‐Drug‐Conjugate Efficacy and Stability
by: Sayumi Yamazoe, et al.
Published: (2025-08-01) -
Antibody-drug conjugates in cancer therapy: applications and future advances
by: Rou Long, et al.
Published: (2025-05-01)